By Riya Gandhi ‘22 The aggressive proliferation of glioblastoma cells is characteristic of glioblastoma multiforme (GBM), a fatal cancer of the brain. As much as treatments may help, patients with this cancer typically relapse. Furthermore, radiotherapy and chemotherapy unintentionally target and poison normal proliferating cells, thereby harming the wellbeing of the patients. However, under principle investigator Dr. Yufeng Shi, researchers at the Cancer Biology & … Continue reading Invasion of the Gboxins: Inhibiting the Proliferation of Glioblastoma Cells
By Allan Mai ‘20 BH4 is an important regulator of many bodily functions. Among its most important functions are its involvement in the production of monoamine neurotransmitters, its generation of nitric oxide, and its role in pain. However, Shane Cronin and his team recently uncovered another important function of this cofactor: proliferation of T cells, which are an integral part of the immune response. Inhibitions … Continue reading BH4’s Role in T- Cell Proliferation in Autoimmunity and Cancer
By Riya Gandhi ‘22 Thanks to chemotherapy, acute myeloid leukemia (AML) is not the most fatal kind of cancer. However, the same chemotherapy that treats the disease may also revitalize leukemia stem cell populations, thereby increasing the probability of relapse. As such, scientists are still actively researching alternative treatments and cures. Most recently, researchers looked into the importance of amino acids for preventing the growth … Continue reading Inducing Leukemia Cell Death Through the Inhibition of Amino Acids
By Riya Gandhi ‘22 Although pancreatic cancer is not the most common type of cancer, the prognosis for those diagnosed with the disease is very poor. Much like any other cancer, pancreatic cancer develops when cells in the organ multiply at an uncontrollable rate. Pancreatic ductal adenocarcinoma (PDA), the most common type of pancreatic cancer, garnered the attention of researchers at Cold Spring Harbor Laboratory … Continue reading Expression of Transcription Factor TP63 Reprograms Squamous Pancreatic Ductal Adenocarcinoma Cells
By Riya Gandhi ‘22 In recent years cancer therapy – especially cancer immunotherapy – has gained momentum and scientists’ interest has turned to immune checkpoint inhibitors (ICIs). ICIs aid in the suppression of checkpoint receptors to produce powerful immune responses against tumors. Although such a procedure is gaining momentum in clinical settings, much research must be done to legitimize this treatment for breast cancer. Under … Continue reading Inducing Tumor Cell Death by RIG-I: The Future of Breast Cancer?
By Riya Gandhi ‘22 In an age in which cancer is the second leading cause of death worldwide, scientists are seeking to discover and develop novel treatments for the disease. Sometimes, although rarely, the answer is just at their fingertips. In a recent study, a team of researchers from the University of Edinburgh sought to understand the mechanism by which 5-nitrofuran antibiotics, also known as … Continue reading Eradicating Subpopulations of Melanoma-Initiating Cells Using Nifuroxazide
By Riya Gandhi ‘22 The location of cancer stem cells in tumors has opened the door to the development of a variety of therapeutic applications. These cells are the future of oncology, and scientists still have much to uncover regarding their various uses in medical treatment. While cancer stem cells are treasure chests of opportunity and have wide scientific application, they are difficult to obtain. … Continue reading From Colon Cancer Cells to Cancer Stem Cells: The Value of Reprogramming Cells